DUBLIN, June 17, 2016 /PRNewswire/ —
Research and Markets has announced the addition of the “Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) – Global Forecasts to 2021” report to their offering.
The global pain management devices market is forecast to reach a value of USD 4.64 Billion by 2021. The growth in this market is primarily driven by factors such as the presence of a large patient population base and adverse effects associated to the use of pain medications.
Based on type, the pain management devices market is categorized into neurostimulation devices (transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS)), ablation devices (RF ablation and cryoablation), and analgesic infusion pumps (intrathecal and external infusion pumps). The neurostimulation devices segment is expected to account for the largest share of the market in 2016. This can majorly be attributed to the cost-effectiveness of neurostimulation devices, high efficacy of TENS and SCS devices in alleviating chronic pain, and availability of reimbursement for SCS therapy in developed countries.
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Pain Management Devices Market, By Type
8 Global Pain Management Devices Market, By Application
9 Global Pain Management Devices Market, By Mode of Purchase
10 Pain Management Devices Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/lfjt9d/pain_management
Research and Markets
Laura Wood, Senior Manager
SOURCE Research and Markets